Nav: Home

As colorectal cancer rate falls, diagnosis of late-stage cancer in young patients is up

June 04, 2016

The National Comprehensive Cancer Network (NCCN) recommends that colorectal cancer (CRC) screening begin at age 50. This means that less is known about the occurrence of the disease in people under age 50. Unfortunately, one thing that is known is that while the overall rate of colorectal cancer continues to decrease, the incidence of the disease in patients under 50 is, in fact, on the rise. A University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2016 seeks to understand this rise in a regional sample of 39,575 patients, finding that in Colorado patients over 50, the rate of CRC is falling at 2.5 percent per year while the rate of CRC in patients under 50 is rising at 0.8 percent per year. The increase in incidence appeared to be driven mostly by an increase in late-stage CRC in the under-50 population with an increase of 2.4 percent per year from 2003 through 2013.

"We hear patients under fifty saying they were told they were too young to have cancer, so not to worry about symptoms. We want young people to be aware that it can happen to them, too. If people are aware of the possibility for colorectal cancer, they're less likely to miss it," says Christopher Lieu, MD, investigator at the CU Cancer Center and assistant professor of medical oncology at the University of Colorado School of Medicine.

The study used data from the Colorado Central Cancer Registry. Overall, the incidence of CRC was about 20 times less in patients under age 50. However, not only is the incidence of young CRC rising, but the majority of these cancers are diagnosed only once they have reached stage IV disease. In fact, the diagnosis of late stage CRC in young patients is rising more than three times as fast as diagnosis of early-stage disease in the same population.

"We're finding this later in young people," Lieu says. Again, this is most likely due in part to screening guidelines that lead to earlier discovery in the over-50 population. Lieu also points out that younger patients (and their doctors) may overlook or discount CRC symptoms that would have been treated more carefully in older patients.

"I think the implication is not that screening age should be decreased. We don't want to do colonoscopies on people who don't need it, which could do more harm than good. What we need is awareness," Lieu says. He points out that awareness can include recognition of symptoms, but may also include awareness of the need for increased care in genetically predisposed populations or those with a family history of the disease. At ASCO 2016, Lieu will also present results showing that CRC in young patients may be genetically distinct from the disease in older patients, leading to a more aggressive profile.

"This is an important finding for the state and an important finding for young patients in general," Lieu says.
-end-


University of Colorado Anschutz Medical Campus

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...